"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...

Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, ...

After years of caring for others, Auckland nurse Zazi Gohar faced her own health crisis when she was diagnosed with multiple ...

A study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that ...

Novartis' new data for Kesimpta showed reduced disability progression in relapsing multiple sclerosis patients. Continuous ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Available disease-modifying therapies can prevent relapses and relapse-associated worsening in people with multiple sclerosis by targeting autoimmunity through various mechanisms. However, these ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

When it comes to living with Multiple Sclerosis, community is everything. That's why one organization is holding a fundraiser ...

Tolebrutinib delayed the onset of disability progression by 31% for patients with a type of the disease called non-relapsing ...

Sanofi has shared data from the phase 3 HERCULES trial that could rescue its multiple sclerosis (MS) drug candidate ...